Back to Search
Start Over
Zoledronic acid and clinical fractures and mortality after hip fracture
- Source :
- The New England Journal of Medicine. Nov 1, 2007, Vol. 357 Issue 18, p1799, 11 p.
- Publication Year :
- 2007
-
Abstract
- The effectiveness of zoledronic acid in prevention of new clinical fractures, to patients undergone hip fracture surgery is studied. Results concluded yearly infusion of zoledronic acid within 90 days of hip fracture surgery reduced risk of new clinical fractures raising survival rate.
Details
- Language :
- English
- ISSN :
- 00284793
- Volume :
- 357
- Issue :
- 18
- Database :
- Gale General OneFile
- Journal :
- The New England Journal of Medicine
- Publication Type :
- Academic Journal
- Accession number :
- edsgcl.171678512